Fate Therapeutics, Inc. (FATE)
$2.44+4.72%Close
SELLCRISIS · day 2
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $284M
- Avg volume
- 3.4M
- Beta
- 2.55
- P/E (TTM)
- -2.32
- Short % float
- 7.54%
- Days to cover
- 4.6
- SI change
- +5.0%
- 1W
- -6.87%
- 1M
- +1.24%
- 3M
- +8.44%
- YTD
- +146.46%
- vs SPY 1W
- -5.68%
- vs SPY 1M
- -2.08%
- vs SPY 3M
- +6.05%
- vs SPY YTD
- +134.71%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- AVRBUYAnteris Technologies Global Corp.RECOVERYQ 31$8.80-2.00%
- NOTVSELLInotiv, Inc.CRISISQ -1$0.01+0.00%
- CATXBUYPerspective Therapeutics, Inc.RECOVERYQ 7$3.19-3.33%
- CLPTBUYClearPoint Neuro, Inc.RECOVERYQ 7$15.17-1.43%
- GELSSELLGelteq Limited Ordinary SharesCRISISQ -13$0.53-5.36%
- ACONBUYAclarion, Inc.RECOVERYQ -29$2.66-1.85%
- XNCRBUYXencor, Inc.BULLQ 17$29.00+4.32%
- RLAYBUYRelay Therapeutics, Inc.BULLQ 4$19.76+1.65%
- LEXXBUYLexaria Bioscience Corp.RECOVERYQ -8$10.54-3.48%
- ALTBUYAltimmune, Inc.RECOVERYQ -5$3.11+0.00%
- BMGLSELLBasel Medical Group Ltd Ordinary SharesCRISISQ -20$4.80-9.43%
- SLNBUYSilence Therapeutics plcRECOVERYQ 3$13.29+0.15%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
